Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.42 |
| ▸ | CRHR1 | P34998 | 2/20 | 0.41 |
| ▸ | ATP4A | P20648 | 4/20 | 0.40 |
| ▸ | ATP4B | P51164 | 4/20 | 0.40 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5135456 | 0.89 | C5AR1 (0.43) | HSD11B1CRHR1ATP4AATP4BC5AR1 | |
| SCHEMBL5072249 | 0.89 | C5AR1 (0.47) | HSD11B1CRHR1ATP4AATP4BC5AR1 | |
| SCHEMBL5134917 | 0.88 | C5AR1 (0.44) | HSD11B1CRHR1ATP4AATP4BC5AR1 | |
| SCHEMBL5135903 | 0.88 | C5AR1 (0.41) | HSD11B1CRHR1ATP4AATP4BC5AR1 | |
| SCHEMBL5073872 | 0.85 | ESR1 (0.42) | HSD11B1CRHR1ATP4AATP4BC5AR1 | |
| SCHEMBL5148382 | 0.85 | CRHR1 (0.41) | HSD11B1CRHR1ATP4AATP4BC5AR1 | |
| SCHEMBL5135106 | 0.84 | C5AR1 (0.47) | HSD11B1CRHR1C5AR1TSHRNR1H3 | |
| SCHEMBL5136847 | 0.84 | MAPT (0.44) | HSD11B1CRHR1ATP4AATP4BC5AR1 | |
| SCHEMBL5137489 | 0.83 | C5AR1 (0.48) | HSD11B1CRHR1ATP4AATP4BC5AR1 | |
| SCHEMBL649970 | 0.83 | C5AR1 (0.62) | C5AR1MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |